|
|
| | 1-Pentyl-3-(1-naphthoyl)indole Basic information |
| | 1-Pentyl-3-(1-naphthoyl)indole Chemical Properties |
| Melting point | 55-59°C | | Boiling point | 534.2±23.0 °C(Predicted) | | density | 1.09±0.1 g/cm3(Predicted) | | Fp | 9℃ | | storage temp. | Desiccate at -20°C | | solubility | DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml; Methanol: 30 mg/ml | | form | A neat solid | | color | white to beige | | InChI | 1S/C24H23NO/c1-2-3-8-16-25-17-22(20-13-6-7-15-23(20)25)24(26)21-14-9-11-18-10-4-5-12-19(18)21/h4-7,9-15,17H,2-3,8,16H2,1H3 | | InChIKey | JDNLPKCAXICMBW-UHFFFAOYSA-N | | SMILES | O=C(C1=CN(CCCCC)C2=C1C=CC=C2)C3=CC=CC4=C3C=CC=C4 |
| | 1-Pentyl-3-(1-naphthoyl)indole Usage And Synthesis |
| Description | JWH 018 (CRM) (Item No. 27973) is a certified reference material categorized as a synthetic cannabinoid. It has been found in Spice/K2-type herbal blends and may have neurotoxic properties. JWH 018 is regulated as a Schedule I compound in the United States. JWH 018 (CRM) (Item No. 27973) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | | Chemical Properties | White Powder | | Uses | Analgesic Drug | | Uses | JWH 018 is the 18th compound synthesized in a series of more than 470 analogs and metabolites of 9-Tetrahydro- cannabinol (THC) (T293200), the active component of marijuana. JWH 018 acts as cannabinoid receptor.
Controlled substance. | | Definition | ChEBI: JWH 018 is an indolecarboxamide. | | Biological Activity | Potent cannabinoid receptor agonist with mild selectivity for CB 2 (K i values are 2.94 and 9.0 nM for CB 2 and CB 1 receptors respectively). | | References | [1] MARIE H DEVENTER. Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo-Pyridyl Synthetic Cannabinoid Receptor Agonist CH-FUBBMPDORA.[J]. Drug Testing and Analysis, 2025. DOI: 10.1002/dta.3854 [2] KATHARINA ELISABETH GRAFINGER. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays[J]. Drug Testing and Analysis, 2021, 13 7: 1412-1429. DOI: 10.1002/dta.3054 [3] ANNELIES CANNAERT. Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA[J]. ACS Chemical Neuroscience, 2020, 11 24: 4434-4446. DOI: 10.1021/acschemneuro.0c00644 |
| | 1-Pentyl-3-(1-naphthoyl)indole Preparation Products And Raw materials |
|